$SATT
SATIVUS TECH CORP. Stock $satt

$satt Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022072146 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$170.0K	$189.0K	$365.0K
YoY Change	-65.16%	-48.22%
% of Gross Profit
Research & Development	$179.0K	$218.0K	$125.0K
YoY Change	-61.75%	74.4%
% of Gross Profit
Depreciation & Amortization	$2.000K	$9.000K	$0.00
YoY Change	-60.0%
% of Gross Profit
Operating Expenses	$349.0K	$218.0K	$490.0K
YoY Change	-63.49%	-55.51%
Operating Profit		-$407.0K	-$490.0K
YoY Change		-16.94%
Interest Expense	-$363.0K	-$435.0K	-$98.00K
YoY Change	611.76%	343.88%
% of Operating Profit
Other Income/Expense, Net		-$435.0K	-$98.00K
YoY Change		343.88%
Pretax Income	-$712.0K	-$842.0K	-$588.0K
YoY Change	-29.29%	43.2%
Income Tax
% Of Pretax Income
Net Earnings	-$631.0K	-$842.0K	-$530.0K
YoY Change	-23.98%	58.87%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.17	-$0.01
Diluted Earnings Per Share	-$0.15	-$0.17	-$139.4K
COMMON SHARES
Basic Shares Outstanding	4.194M shares	4.194M shares	3.802M shares
Diluted Shares Outstanding		4.194M shares	3.802M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$810.0K	$191.0K	$916.0K
YoY Change	-6.47%	-79.15%
Cash & Equivalents	$810.0K	$191.0K	$916.0K
Short-Term Investments
Other Short-Term Assets	$85.00K	$40.00K	$190.0K
YoY Change	10.39%	-78.95%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$901.0K	$242.0K	$1.106M
YoY Change	-6.44%	-78.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$219.0K	$209.0K	$11.00K
YoY Change	3550.0%	1800.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$249.0K	$243.0K	$11.00K
YoY Change	378.85%	2109.09%
TOTAL ASSETS
Total Short-Term Assets	$901.0K	$242.0K	$1.106M
Total Long-Term Assets	$249.0K	$243.0K	$11.00K
Total Assets	$1.150M	$485.0K	$1.117M
YoY Change	13.3%	-56.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$55.00K	$33.00K	$33.00K
YoY Change	358.33%	0.0%
Accrued Expenses	$32.00K	$15.00K
YoY Change	60.0%
Deferred Revenue
YoY Change
Short-Term Debt	$2.145M	$2.176M	$1.886M
YoY Change	-28.36%	15.38%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.719M	$3.637M	$2.820M
YoY Change	10.75%	28.97%
LONG-TERM LIABILITIES
Long-Term Debt		$20.00K	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$20.00K	$0.00
YoY Change	-100.0%
Total Long-Term Liabilities		$20.00K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.719M	$3.637M	$2.820M
Total Long-Term Liabilities		$20.00K	$0.00
Total Liabilities	$3.719M	$3.657M	$2.959M
YoY Change	9.8%	23.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.60M	-$21.97M
YoY Change	7.24%
Common Stock	$4.000K	$4.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.844M	-$3.119M	-$1.842M
YoY Change
Total Liabilities & Shareholders Equity	$1.150M	$485.0K	$1.117M
YoY Change	13.3%	-56.58%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$631.0K	-$842.0K	-$530.0K
YoY Change	-23.98%	58.87%
Depreciation, Depletion And Amortization	$2.000K	$9.000K	$0.00
YoY Change	-60.0%
Cash From Operating Activities	-$253.0K	-$239.0K	-$408.0K
YoY Change	427.08%	-41.42%
INVESTING ACTIVITIES
Capital Expenditures	$7.000K	$0.00	$0.00
YoY Change	40.0%
Acquisitions
YoY Change
Other Investing Activities	$5.000K	$0.00	$0.00
YoY Change	-600.0%
Cash From Investing Activities	-$2.000K	$0.00	$0.00
YoY Change	-150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	874.0K	288.0K	0.000
YoY Change	-14666.67%
NET CHANGE
Cash From Operating Activities	-253.0K	-239.0K	-408.0K
Cash From Investing Activities	-2.000K	0.000	0.000
Cash From Financing Activities	874.0K	288.0K	0.000
Net Change In Cash	619.0K	49.00K	-408.0K
YoY Change	-1338.0%	-112.01%
FREE CASH FLOW
Cash From Operating Activities	-$253.0K	-$239.0K	-$408.0K
Capital Expenditures	$7.000K	$0.00	$0.00
Free Cash Flow	-$260.0K	-$239.0K	-$408.0K
YoY Change	390.57%	-41.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Entity File Number EntityFileNumber	333-208814
	dei	Entity Registrant Name EntityRegistrantName	SATIVUS TECH CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2847446
	dei	Entity Address Address Line1 EntityAddressAddressLine1	#3 Bethesda Metro Center
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#700
	dei	Entity Address City Or Town EntityAddressCityOrTown	Bethesda
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06880
	dei	City Area Code CityAreaCode	800
	dei	Local Phone Number LocalPhoneNumber	608-6432
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4194385	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	191000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	866000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	11000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	20000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	40000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	77000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	242000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	963000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	34000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	46000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	209000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6000	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	243000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	52000	usd
CY2022Q3	us-gaap	Assets Assets	485000	usd
CY2021Q4	us-gaap	Assets Assets	1015000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	33000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	111000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	110000	usd
CY2022Q3	us-gaap	Convertible Debt ConvertibleDebt	2176000	usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	2994000	usd
CY2022Q3	satt	Fair Value Of Convertible Component In Convertible Loans Non Current FairValueOfConvertibleComponentInConvertibleLoansNonCurrent	1302000	usd
CY2021Q4	satt	Fair Value Of Convertible Component In Convertible Loans Non Current FairValueOfConvertibleComponentInConvertibleLoansNonCurrent	222000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3637000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3358000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	20000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	29000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	3657000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3387000	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4194385	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4194385	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4194385	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4194385	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18850000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18595000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21973000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21077000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3119000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2478000	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	-53000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	106000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3172000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2372000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	485000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1015000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	218000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	125000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	494000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	443000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	50000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	131000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	189000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	315000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	490000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1020000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-407000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-490000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-984000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1594000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-435000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-98000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-117000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1340000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-842000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-588000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1101000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2934000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-110000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-58000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-205000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-145000	usd
CY2022Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-732000	usd
CY2021Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-530000	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-896000	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-2789000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4194385	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3801535	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4194385	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3415457	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2046000	usd
CY2021Q1	satt	Stock Issued During Period Value Transactions With Noncontrolling Parties StockIssuedDuringPeriodValueTransactionsWithNoncontrollingParties	1406000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	27000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	530000	usd
CY2021Q1	satt	Issuance Of Warrants IssuanceOfWarrants	39000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	334000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2231000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1941000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	17000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	260000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-115000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1779000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	119000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	545000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-588000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1703000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2372000	usd
CY2022Q1	satt	Share Based Compensation To Employees And Nonemployee ShareBasedCompensationToEmployeesAndNonemployee	147000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	40000	usd
CY2022Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited	211000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	421000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1975000	usd
CY2022Q2	satt	Share Based Compensation To Employees And Nonemployee ShareBasedCompensationToEmployeesAndNonemployee	127000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	35000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-680000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2493000	usd
CY2022Q3	satt	Stock Issued During Period Value Transactions With Noncontrolling Parties StockIssuedDuringPeriodValueTransactionsWithNoncontrollingParties	100000	usd
CY2022Q3	satt	Share Based Compensation To Employees And Nonemployee ShareBasedCompensationToEmployeesAndNonemployee	50000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	13000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-842000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3172000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1101000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2934000	usd
	us-gaap	Depreciation Depreciation	36000	usd
	us-gaap	Depreciation Depreciation	1000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	172000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	496000	usd
	satt	Financial Expenses Related To Loans From Related Party FinancialExpensesRelatedToLoansFromRelatedParty	-980000	usd
	satt	Financial Expenses Related To Loans From Related Party FinancialExpensesRelatedToLoansFromRelatedParty	166000	usd
	satt	Change In Fair Value Of Convertible Component In Convertible Loan ChangeInFairValueOfConvertibleComponentInConvertibleLoan	1081000	usd
	satt	Change In Fair Value Of Convertible Component In Convertible Loan ChangeInFairValueOfConvertibleComponentInConvertibleLoan	1222000	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	37000	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-164000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-21000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	18000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	1000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-95000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-733000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1326000	usd
	satt	Decrease Increase In Restricted Cash DecreaseIncreaseInRestrictedCash	-9000	usd
	satt	Decrease Increase In Restricted Cash DecreaseIncreaseInRestrictedCash	19000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	199000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-190000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	239000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	530000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-16000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	75000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	74000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	100000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1406000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	248000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1862000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-675000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	505000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	866000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	411000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	916000	usd
	us-gaap	Interest Paid Net InterestPaidNet	75000	usd
	us-gaap	Stock Issued1 StockIssued1	8050000	usd
	satt	Purchase Of Fixed Assets By Issuance Of Share Capital PurchaseOfFixedAssetsByIssuanceOfShareCapital	28000	usd
CY2022Q3	us-gaap	Other Receivables OtherReceivables	100000	usd
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	76890	shares
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	4.5
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.36
	satt	Maximum Amount Assuming MaximumAmountAssuming	5000000	ils
	satt	Saffron Tech Has Raised SaffronTechHasRaised	2000000	ils
	us-gaap	Sale Of Stock Percentage Of Ownership Before Transaction SaleOfStockPercentageOfOwnershipBeforeTransaction	0.75	pure
CY2022Q2	satt	Retained Earning Accumulated Deficit RetainedEarningAccumulatedDeficit	22005000	usd
	satt	Operating Cash Flow OperatingCashFlow	732000	usd
	satt	Options Vest Description OptionsVestDescription	The options vest on a quarterly basis over a period between two and three years and expire on January 4, 2032.
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	281000	usd
CY2022Q3	satt	Exercisable Options Per Share ExercisableOptionsPerShare	3.96
CY2022Q3	us-gaap	Federal Home Loan Bank Borrowings Fair Value Disclosure FederalHomeLoanBankBorrowingsFairValueDisclosure	1302000	usd
CY2022Q3	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	1302000	usd
CY2021Q4	us-gaap	Federal Home Loan Bank Borrowings Fair Value Disclosure FederalHomeLoanBankBorrowingsFairValueDisclosure	222000	usd
CY2021Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	222000	usd
	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.20	pure
CY2022Q3	us-gaap	Fair Value Concentration Of Risk Investments FairValueConcentrationOfRiskInvestments	157000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	18
CY2022Q3	satt	Gross Proceeds GrossProceeds	239000	usd
	us-gaap	Temporary Equity Elimination As Partof Reorganization TemporaryEquityEliminationAsPartofReorganization	2000000	usd
CY2022Q3	us-gaap	Capitalization Longterm Debt And Equity CapitalizationLongtermDebtAndEquity	5000000	usd
	us-gaap	Malpractice Loss Contingency Discount Rate MalpracticeLossContingencyDiscountRate	0.80	pure
CY2022Q3	us-gaap	Capital Leases Indemnification Agreements Description CapitalLeasesIndemnificationAgreementsDescription	the Company and the February 2019 Lender, October 2019 Lender and the August 2020 Lender (all the same entity) entered in an agreement (“Payoff Agreement”) pursuant to which, should the Company raise at least $2,250 by December 31, 2022, the February 2019 Loan, the October 2019 Loan and the August 2020 Loan (together the “Convertible Loans”) would be forgiven in return for $750 in cash (“Payoff Amount”). The Payoff Agreement further provides that should the Company not repay the entire Payoff Amount by December 31, 2022 but is able to raise between $250 and $2,250 by December 31, 2022 then the Company will make certain payments (between 0%-30% of amounts raised) towards repayment of the original capital amount owing on the Convertible Loans.
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	189000	usd
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	159000	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	37000	usd
CY2021	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	22000	usd
CY2022Q1	satt	Exercisable Options Per Share ExercisableOptionsPerShare	1.29
CY2022Q1	satt	Exercisable Options Per Share ExercisableOptionsPerShare	4
	us-gaap	Intermediate Life Plants Useful Life IntermediateLifePlantsUsefulLife	P10Y
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	2.23	pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.1
CY2021	satt	Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	120000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.01
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate	0.0171	pure
	srt	Short Term Investments Other Average Yield ShortTermInvestmentsOtherAverageYield	0	pure
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	245000	usd
	satt	Amount Of Cancelled Share Options AmountOfCancelledShareOptions	211000	usd
	satt	Schedule Of Warrant Activity ScheduleOfWarrantActivity	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Average<br/> exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Warrants outstanding at January 1, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">213,083</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.81</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">99,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(66,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(47,333</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.94</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Warrants outstanding at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">198,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.54</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(13,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-85">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Warrants outstanding at September 30, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">185,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.43</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p>
CY2020Q4	satt	Number Of Warrant Outstanding NumberOfWarrantOutstanding	213083	shares
CY2020Q4	satt	Average Exercise Price Warrant Outstanding AverageExercisePriceWarrantOutstanding	0.81
CY2021	satt	Number Warrant Granted NumberWarrantGranted	99000	shares
CY2021	satt	Average Exercise Price Warrants Granted AverageExercisePriceWarrantsGranted	0.15
CY2021	satt	Numbers Warrant Forfeited Cancelled NumbersWarrantForfeitedCancelled	66000	shares
CY2021	satt	Average Exercise Prices Forfeited Cancelled AverageExercisePricesForfeitedCancelled	0.15
CY2021	satt	Number Warrant Forfeited Cancelled NumberWarrantForfeitedCancelled	47333	shares
CY2021	satt	Average Exercise Price Forfeited Cancelled AverageExercisePriceForfeitedCancelled	1.94
CY2021Q4	satt	Number Of Warrant Outstanding NumberOfWarrantOutstanding	198750	shares
CY2021Q4	satt	Average Exercise Price Warrant Outstanding AverageExercisePriceWarrantOutstanding	0.54
	satt	Number Warrant Expired NumberWarrantExpired	-13750	shares
	satt	Average Exercise Price Expired AverageExercisePriceExpired	2
CY2022Q3	satt	Number Of Warrant Outstanding NumberOfWarrantOutstanding	185000	shares
CY2022Q3	satt	Average Exercise Price Warrant Outstanding AverageExercisePriceWarrantOutstanding	0.43
CY2021	satt	Warrants Outstanding Shares WarrantsOutstandingShares	198750	shares
CY2021	satt	Class Of Warrant Or Righst Warrant Or Right Exercisable ClassOfWarrantOrRighstWarrantOrRightExercisable	198750	shares
	satt	Warrants Outstanding Shares WarrantsOutstandingShares	185000	shares
	satt	Class Of Warrant Or Righst Warrant Or Right Exercisable ClassOfWarrantOrRighstWarrantOrRightExercisable	185000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	166000	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	195000	shares
CY2021	satt	Number Options Exercised NumberOptionsExercised	90000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.1
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	195000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.63
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	195000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.63
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	171250	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.7
	satt	Class Of Warrant Or Righst Warrants Or Rights Exercisable ClassOfWarrantOrRighstWarrantsOrRightsExercisable	166250	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	49025	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	227500	shares
CY2021	satt	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised	-80525	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	196000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	30000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	166000	shares
CY2022Q3	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	-446000	usd
CY2021Q3	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	-108000	usd
	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	-100000	usd
	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	-1318000	usd
	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant	39000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-9000	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-10000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	17000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-17000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	435000	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	98000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	117000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1340000	usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-09-11
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	23000	usd
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	In the first 3 years of sales the Company shall pay 3% of the sales of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales, the Company shall pay 4% of such sales and from the seventh year onwards the Company shall pay 5% of up to 100% of the amount of grants received plus interest at LIBOR.
	us-gaap	Subsequent Event Description SubsequentEventDescription	Assuming the maximum amount (NIS 5 million) is raised, the Company will own approximately 61% of Saffron Tech.
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	satt	Purchase Of Fixed Assets By Issuance Of Share Capital PurchaseOfFixedAssetsByIssuanceOfShareCapital		usd
CY2021	satt	Number Of Warrant Exercised NumberOfWarrantExercised		shares
CY2021	satt	Average Exercise Price Warrant Exercised AverageExercisePriceWarrantExercised
	satt	Number Of Warrant Exercised NumberOfWarrantExercised		shares
	satt	Average Exercise Price Warrant Exercised AverageExercisePriceWarrantExercised
	satt	Number Warrant Forfeited Cancelled NumberWarrantForfeitedCancelled		shares
	satt	Average Exercise Price Forfeited Cancelled AverageExercisePriceForfeitedCancelled
	satt	Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	satt	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised		shares
CY2022Q3	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant		usd
CY2021Q3	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant		usd
	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant		usd
CY2022Q3	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001661600

Files In Submission

Name	View Source	Status
satt-20220930_def.xml	Edgar Link	unprocessable
satt-20220930_lab.xml	Edgar Link	unprocessable
0001213900-22-072146-index-headers.html	Edgar Link	pending
0001213900-22-072146-index.html	Edgar Link	pending
0001213900-22-072146.txt	Edgar Link	pending
0001213900-22-072146-xbrl.zip	Edgar Link	pending
f10q0922ex31-1_sativustech.htm	Edgar Link	pending
f10q0922ex31-2_sativustech.htm	Edgar Link	pending
f10q0922ex32-1_sativustech.htm	Edgar Link	pending
f10q0922ex32-2_sativustech.htm	Edgar Link	pending
f10q0922_sativustechcorp.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
satt-20220930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
satt-20220930_cal.xml	Edgar Link	unprocessable
f10q0922_sativustechcorp_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending
satt-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SATT
SATIVUS TECH CORP. Stock $satt

2022 Q4 Form 10-Q Financial Statement

#000121390022072146 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SATT SATIVUS TECH CORP. Stock $satt

2022 Q4 Form 10-Q Financial Statement

#000121390022072146 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SATT
SATIVUS TECH CORP. Stock $satt